Austrian biotech Themis launches Zika vaccine clinical trial
Reuters Austrian biotech company Themis Bioscience said on Tuesday it had started a clinical trial of an experimental Zika vaccine in healthy volunteers, opening up another front in the race to prevent the spread of the mosquito-borne disease. Themis's product ... |
from Health - Google News http://ift.tt/2onQ5aT
EmoticonEmoticon